Albert Chiu

Albert Chiu is a Senior Associate at Ampersand Capital Partners as of August 2023. Previous experience includes roles at Danaher Corporation, where responsibilities included corporate strategy focusing on M&A in cell and gene therapy and mRNA bioprocess technologies, and serving as a Process Engineer II at Pall Biotech, developing bioprocess solutions for biopharmaceutical manufacturing. Additionally, Albert Chiu participated in a Leadership Development Program at Beckman Coulter, working on diagnostic test design and engineering, and held internships in operations strategy at GE Healthcare and drug development at Theravance Biopharma US, Inc. Academic credentials include an MBA from Harvard Business School and a B.S. in Chemical and Biomolecular Engineering from the University of California, Berkeley, along with cross-registration at the Massachusetts Institute of Technology.